Clinical trial

Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer

NCT03327662

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-01-11

PhasePHASE3

Study timeline

Study start (actual)2017-01-11Date precision: day

Registry last updated2021-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adenocarcinoma of the Prostateunresolved

Interventions

Active CTC AssessmentOTHER

Sponsors & collaborators

Institute of Cancer Research, United Kingdomlead sponsor

Prostate Cancer UKcollaborator

University of Twentecollaborator

Sanoficollaborator

Janssen, LPcollaborator

Menarini Groupcollaborator

Mapped research locations

LondonUnited Kingdom1 EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03327662 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.